Endoscopic Sleeve Gastroplasty Is a Treatment Option for Obesity

This endoscopic procedure resulted in less weight loss but also fewer adverse events compared with laparoscopic sleeve gastrectomy.

The most commonly performed procedure to treat obesity is laparoscopic sleeve gastrectomy (LSG), which carries a risk for new-onset gastroesophageal reflux disease (GERD). Endoscopic sleeve gastroplasty (ESG) is a new endoscopic alternative that mimics the restrictive anatomical changes produced by LSG, while maintaining the anatomical structure of the stomach.

In a single-center, retrospective study, researchers compared outcomes in 54 patients who underwent ESG and 83 matched patients who underwent LSG. Despite matching, LSG patients had higher rates of diabetes mellitus, hypertension, and obstructive sleep apnea. At 6 months postprocedure, percent total body weight loss was greater in LSG patients than in ESG patients (24% vs. 17%). Howev…

Reviewing Author

John R. Saltzman, MD

Disclosures

Consultant/Advisory BoardIterative Scopes

Editorial BoardsGastrointestinal Endoscopy; UpToDate

Leadership Positions in Professional SocietiesAmerican College of Gastroenterology (Trustee)

OtherVice President of Medical Affairs, 1Globe Health Institute